Reading, United Kingdom

Dean Rivers

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Spero Therapeutics, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dean Rivers. Retrieved from https://idiyas.com/inventor/dean-rivers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dean Rivers - Innovator in Polymyxin Compounds

Introduction

Dean Rivers is a notable inventor based in Reading, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his work on polymyxin compounds. His innovative approach has led to advancements in the treatment of microbial infections.

Latest Patents

Dean Rivers holds 1 patent for his invention related to polymyxin compounds. The patent provides a polymyxin compound of formula (I) along with its salts, solvates, and protected forms. It also includes pharmaceutical compositions comprising these compounds and outlines their use in methods of treatment for microbial infections.

Career Highlights

Dean Rivers is currently associated with Spero Therapeutics, Inc., where he continues to develop and refine his innovative ideas. His work has been instrumental in advancing therapeutic options for patients suffering from various infections.

Collaborations

Throughout his career, Dean has collaborated with talented individuals such as Pamela Brown and Michael Dawson. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in the pharmaceutical industry.

Conclusion

Dean Rivers exemplifies the spirit of innovation in the pharmaceutical field with his work on polymyxin compounds. His contributions are paving the way for new treatment options and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…